SAC重组腺相关病毒载体的构建及其对前列腺癌CAM移植瘤的抑制作用

山东大学学报(医学版) ›› 2012, Vol. 50 ›› Issue (7): 41-.

SAC重组腺相关病毒载体的构建及其对前列腺癌CAM移植瘤的抑制作用

于张健1，张士宝1，刘庆勇1，阮喜云2，杨广笑3，王全颖3

1.山东大学附属济南市中心医院泌尿外科, 济南 250013；
2.山东大学附属省立医院神经内科，济南 250021；
3.西安华广生物工程有限公司，西安 710025

收稿日期:2011-12-02 出版日期:2012-07-10 发布日期:2012-07-10
通讯作者: 刘庆勇(1962- )，男，博士研究生，副教授，主要从事泌尿系肿瘤及肾移植的研究。 E-mail:lqylbc@163.com
作者简介:于张健(1985- )，男，硕士研究生，主要从事前列腺肿瘤研究。 E-mail: yuzhangjian@yahoo.cn
基金资助:
济南市科技发展计划(200815028)

Construction of a recombinant adenoassociated viral vector expressing SAC and its inhibition on CAM xenograft prostate cancer

YU Zhang-jian1, ZHANG Shi-bao1, LIU Qing-yong1, RUAN Xi-yun2, YANG Guang-xiao3, WANG Quan-ying3

1. Department of Urology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China;
2. Department of Neurology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China;
3. Xi’an Huaguang Biological Engineering Limited Company, Xi’an 710025, China

Received:2011-12-02 Online:2012-07-10 Published:2012-07-10

摘要/Abstract

摘要：

目的构建携带NT4-SAC-HA2-TAT融合基因的重组腺相关病毒载体，并感染前列腺癌鸡胚绒毛尿囊膜(CAM)移植瘤，观察目的基因前列腺凋亡反应基因4(par-4)选择性癌细胞凋亡结构域(SAC)的表达及其对CAM移植瘤的生长抑制作用。方法利用磷酸钙共沉淀法将包装质粒pAAV/Ad、腺病毒辅助质粒pFG140及重组穿梭质粒pSSCMV/NT4-SAC-HA2-TAT共转染293细胞，制备重组腺相关病毒(rAAV), 斑点杂交法检测病毒滴度。取孵育9d龄健康鸡胚，CAM接种前列腺癌细胞系PC3细胞，建立前列腺癌的CAM移植瘤模型，接种3d后挑选成瘤鸡胚随机分为3组：空白对照组(PBS)，空病毒组(AAV)和重组病毒组(rAAV)，观察瘤体生长情况，上述处理4d后测量比较不同组移植瘤体积，并切片染色病理检查。免疫荧光法检测移植瘤中SAC融合肽的表达。结果酶切鉴定结果证实成功构建pSSCMV/NT4-SAC-HA2-TAT, 斑点杂交法检测重组病毒滴度约为3.34×1010～3.34×1011cfu/mL。免疫荧光法证实SAC融合肽表达。移植瘤能在CAM上生长，可见瘤周围丰富毛细血管汇集，rAAV组瘤体显著缩小，病理HE染色可见瘤细胞局限及侵袭抑制。结论成功构建SAC重组腺相关病毒载体并感染前列腺癌CAM移植瘤，重组病毒表达分泌的SAC融合肽对前列腺癌CAM移植瘤具有诱导细胞凋亡、抑制肿瘤细胞侵袭性增殖等作用。

关键词: 前列腺凋亡反应基因4选择性癌细胞凋亡结构域；重组腺相关病毒；鸡胚绒毛尿囊膜；雄激素非依赖性前列腺癌；移植瘤; 基因治疗

Abstract:

Objective To construct a recombinant adeno-associated virus expression plasmid containing a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells (SAC) and protein transduction domain TAT, and investigate the effect of the SAC on chick chorioallantoic membrane (CAM) xenograft prostate cancer. Methods Plasmids pAAV/Ad, pFG140 and pSSCMV/NT4-SAC-HA2-TAT were transfected into 293 cells by method of Ca3(P04)2 to harvest rAAV-NT4-SAC-HA2-TAT whose titer was detected by dot blot. PC-3 cells were grafted on CAM in the 9th day of the embryonic development to construct the CAM xenograft tumor model of prostate cancer. The growth of xenograft tumor and richness of CAM capillaries around tumor were observed and photographed. 3 days later， those chick embryos with tumor formation were randomly divided into three groups (the PBS group, the AAV group，and the rAAV group). The tumors of different groups were compared on the volume 4 days after the treatment and fixed with formalin for further analyzation using standard histopathology. The expression of SAC was detected with immunofluorescence method. Results Recombinant plasmid pSSCMV/NT4-SAC-HA2-TAT was successfully constructed confirmed by restriction enzyme digestion. The viral titer was about 3.34×1010～3.34×1011cfu/mL detected by dot blot. The expression of SAC fusion peptide in the tumor tissue was detected by immunefluorescence test. The xenograft tumor could grow on the CAM, and a mass of capillaries around the tumor were observed. Tumors in the rAAV group significantly shrank. The invasiveness of PC-3 cells was inhibited and the tumor cells distributions were limited under the microscope. Conclusion The xenograft tumor model of prostate cancer on CAM is established successfully. Fusion peptide of SAC plays a significant role in inhibiting the invasiveness and inducting the apoptosis of PC-3 cells.

Key words: Par-4-SAC; Recombinant adeno-associated virus; Chick chorioallantoic membrane; Androgenindependent prostate cancer; Xenograft tumor; Gene therapy

中图分类号:

R737.25

于张健1，张士宝1，刘庆勇1，阮喜云2，杨广笑3，王全颖3. SAC重组腺相关病毒载体的构建及其对前列腺癌CAM移植瘤的抑制作用[J]. 山东大学学报(医学版), 2012, 50(7): 41-.

YU Zhang-jian1, ZHANG Shi-bao1, LIU Qing-yong1, RUAN Xi-yun2, YANG Guang-xiao3, WANG Quan-ying3. Construction of a recombinant adenoassociated viral vector expressing SAC and its inhibition on CAM xenograft prostate cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 41-.

参考文献

相关文章 11

[1]	高逢彬，司曼飞，刘永青，牛蕾蕾，苑辉卿. 网脊衣酸上调p21CIP1蛋白诱导前列腺癌细胞周期阻滞的作用分析[J]. 山东大学学报(医学版), 2013, 51(12): 34-40.
[2]	郭晓宇1，姜燕2，邢召全3，郭兆新3，房志卿3，刘照旭1,3. DNA甲基化酶抑制剂对前列腺癌中XAF1 mRNA表达的影响[J]. 山东大学学报(医学版), 2012, 50(12): 94-.
[3]	郑桂喜，王传新，张欣，李伟，杜鲁涛，李娟，刘慧. 全人源抗前列腺癌ScFv抗体的筛选及生物学特性研究[J]. 山东大学学报(医学版), 2012, 50(11): 34-38.
[4]	萧畔1,张怀强1,崔亚洲2,赵升田1,马天加1,周春文1. 多西紫杉醇诱导前列腺癌PC3细胞凋亡的蛋白质组学研究[J]. 山东大学学报(医学版), 2012, 50(10): 77-.
[5]	韩博1,3,杨晓庆1,张晶2,刘文君3,刘龙3. SPINK1在前列腺癌中的基础及临床转化研究进展[J]. 山东大学学报(医学版), 2012, 50(8): 40-.
[6]	王海滨，马伟明，萧畔，马天加，张怀强. 热休克蛋白60在多西紫杉醇治疗激素非依赖性前列腺癌过程中的差异表达[J]. 山东大学学报(医学版), 2012, 50(8): 46-50.
[7]	陈兆波，刘春艳，倪娜娜，于洋，张鹏举，陈蔚文，姜安丽. miR Let-7a1/f1下调前列腺癌1LNCaP细胞中AMD1蛋白的表达[J]. 山东大学学报(医学版), 2012, 50(1): 29-.
[8]	张士宝刘庆勇阮喜云陈杰张建军李宗武杨广笑王全颖. NT₄-SAC-HA₂-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[9]	高德轩夏庆华吕家驹张辉. 丙戊酸长期给药对抑制PC3细胞系裸鼠移植瘤生长的影响[J]. 山东大学学报(医学版), 2008, 46(12): 1158-1161.
[10]	. 前列腺癌细胞LNCaP中雄激素依赖性和雄激素非依赖性蛋白差异性表达研究[J]. 山东大学学报(医学版), 2009, 47(9): 62-65.
[11]	张士宝刘庆勇阮喜云陈杰张建军李宗武杨广笑王全颖. NT₄-SAC-HA₂-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2009, 47(6): 15-19.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed